IGHA1 and IgA glomerulonephritis: 4) Underexplored therapeutic strategies and model limitations: Preclinical studies have relied on in vitro mesangial cell models and lack validated animal models that fully recapitulate human IgA nephropathy’s pathological features (e.g., glomerular IgA1 deposition and mesangial proliferation).